Cargando…

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score

Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased cardiovascular morbidity and mortality. The anti-arrhythmic effect of statins on AF prevention appears to be highly significant in most clinical studies. However, some discrepancies do exist among different clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Chen-Ying, Hsieh, Yu-Cheng, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117839/ https://www.ncbi.nlm.nih.gov/pubmed/25089130 http://dx.doi.org/10.4070/kcj.2014.44.4.205

Ejemplares similares

Assessment of CHADS(2) and CHA(2)DS(2)-VASc scores in obstructive sleep apnea patients with atrial fibrillation
por: Szymanski, Filip M., et al.
Publicado: (2014)

CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery
por: Yin, Liang, et al.
Publicado: (2015)

Predictive value of CHADS(2) and CHA(2)DS(2)-VASc scores for acute myocardial infarction in patients with atrial fibrillation
por: Pang, Hui, et al.
Publicado: (2017)

Mortality prediction using CHADS(2)/CHA(2)DS(2)-VASc/R(2)CHADS(2) scores in systolic heart failure patients with or without atrial fibrillation
por: Chen, Yung-Lung, et al.
Publicado: (2017)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
por: Al-Turaiki, Abdulrahman M., et al.
Publicado: (2016)

CHADS(2) and modified CHA(2)DS(2)-VASc scores for the prediction of congestive heart failure in patients with nonvalvular atrial fibrillation
por: Koeda, Yorihiko, et al.
Publicado: (2017)

Association between big endothelin-1 and CHADS(2)/CHA(2)DS(2)-VASc scores in non-valvular atrial fibrillation
por: Zheng, Li-Hui, et al.
Publicado: (2019)

Relationship of CHA(2)DS(2)-VASc and CHADS(2) Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation
por: Li, Yihui, et al.
Publicado: (2013)

CHADS(2) score has a better predictive value than CHA(2)DS(2)-VASc score in elderly patients with atrial fibrillation
por: Xing, Yunli, et al.
Publicado: (2016)

Comparison of the CHADS(2), CHA(2)DS(2)-VASc and R(2)CHADS(2) Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy
por: Yoshizawa, Reisuke, et al.
Publicado: (2017)

Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients
por: Wu, Yuzhong, et al.
Publicado: (2021)

Correction: Relationship of CHA(2)DS(2)-VASc and CHADS(2) Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation
por: Li, Yihui, et al.
Publicado: (2013)

Association of the CHADS(2) and CHA(2)DS(2)-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients
por: Hrynkiewicz-Szymanska, Anna, et al.
Publicado: (2014)

Refinement of CHADS2 and CHA2DS2-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients
por: Cao, Miaomiao, et al.
Publicado: (2022)

Left atrial spontaneous echo contrast occurring in patients with low CHADS(2) or CHA(2)DS(2)-VASc scores
por: Akamatsu, Kanako, et al.
Publicado: (2020)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

CHADS(2) and CHA(2)DS(2)-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation
por: Wu, Jin-Tao, et al.
Publicado: (2017)

CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
por: Yu, Inwu, et al.
Publicado: (2021)

Using CHADS(2) and CHA(2)DS(2)-VASc scores for mortality prediction in patients with chronic kidney disease
por: Hsu, Po-Chao, et al.
Publicado: (2020)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

The impact of cigarette smoking in predicting stroke using CHADS(2) and CHA(2)DS(2)-VASc schemas
por: Zuo, Ming-Liang, et al.
Publicado: (2020)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023)

Decreased Renal Function Is Associated with Elevated CHA2DS2VASC and R2CHADS2 Scores in Non-Valvular Atrial Fibrillation Patients Presenting with Stroke
por: Vindhyal, Mohinder, et al.
Publicado: (2017)

Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA(2)DS(2)-VASc Score
por: Lin, Yu-Sheng, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

CHADS(2) versus CHA(2)DS(2)-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis
por: Chen, Jia-Yuan, et al.
Publicado: (2013)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

Age and CHADS(2) Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation
por: Hung, Chen-Ying, et al.
Publicado: (2015)

CHADS(2) and CHA(2)DS(2)-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome
por: Svendsen, Jesper Hastrup, et al.
Publicado: (2013)

Prognostic significance of CHADS(2) and CHA(2)DS(2)-VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19
por: Montazeri, Mahnaz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btimgnqdp2a87o985n5u1d1s9s